Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
[Nicolau syndrome after administration of glatiramer acetate].
Puma, but not noxa is essential for oligodendroglial cell death.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Shorter washout reduces MS relapse switching off natalizumab
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
[Infections and fingolimod].
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Substance Name: Amiloride
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Pages
« first
‹ previous
…
129
130
131
132
133
134
135
136
137
…
next ›
last »